Syros Pharmaceuticals Inc (SYRS)
5.13
-0.07
(-1.35%)
USD |
NASDAQ |
May 03, 16:00
5.13
0.00 (0.00%)
After-Hours: 20:00
Syros Pharmaceuticals 1 Year Total Returns (Daily): 71.57% for May 3, 2024
1 Year Total Returns (Daily) Chart
Historical 1 Year Total Returns (Daily) Data
Date | Value |
---|---|
May 03, 2024 | 71.57% |
May 02, 2024 | 76.27% |
May 01, 2024 | 67.90% |
April 30, 2024 | 69.81% |
April 29, 2024 | 69.18% |
April 26, 2024 | 60.00% |
April 25, 2024 | 70.00% |
April 24, 2024 | 79.79% |
April 23, 2024 | 92.51% |
April 22, 2024 | 86.89% |
April 19, 2024 | 69.40% |
April 18, 2024 | 75.46% |
April 17, 2024 | 97.30% |
April 16, 2024 | 105.9% |
April 15, 2024 | 98.15% |
April 12, 2024 | 105.7% |
April 11, 2024 | 118.5% |
April 10, 2024 | 113.5% |
April 09, 2024 | 119.6% |
April 08, 2024 | 79.64% |
April 05, 2024 | 82.42% |
April 04, 2024 | 81.89% |
April 03, 2024 | 94.53% |
April 02, 2024 | 73.60% |
April 01, 2024 | 88.76% |
Date | Value |
---|---|
March 28, 2024 | 98.15% |
March 27, 2024 | 110.8% |
March 26, 2024 | 128.1% |
March 25, 2024 | 133.6% |
March 22, 2024 | 121.6% |
March 21, 2024 | 124.0% |
March 20, 2024 | 133.6% |
March 19, 2024 | 120.9% |
March 18, 2024 | 116.3% |
March 15, 2024 | 94.50% |
March 14, 2024 | 99.67% |
March 13, 2024 | 96.66% |
March 12, 2024 | 106.4% |
March 11, 2024 | 109.6% |
March 08, 2024 | 70.96% |
March 07, 2024 | 72.39% |
March 06, 2024 | 80.96% |
March 05, 2024 | 81.93% |
March 04, 2024 | 93.38% |
March 01, 2024 | 111.7% |
February 29, 2024 | 93.09% |
February 28, 2024 | 91.22% |
February 27, 2024 | 103.9% |
February 26, 2024 | 104.1% |
February 23, 2024 | 88.08% |
Total Return Definition
The Total return is the change in price over a specific period of time that includes dividends and distributions paid.
1 Year Total Returns (Daily) Range, Past 5 Years
-91.85%
Minimum
Nov 09 2022
159.3%
Maximum
Dec 15 2020
-23.65%
Average
-41.39%
Median
Sep 08 2021
1 Year Total Returns (Daily) Benchmarks
PDS Biotechnology Corp | -39.17% |
PAVmed Inc | -73.54% |
Moderna Inc | -3.95% |
Altimmune Inc | 46.59% |
iBio Inc | -90.87% |